Document is current
Any future updates will be listed below
-
Authors
van Wijk, Meike W. M. https://orcid.org/0000-0002-4626-6694
van Wolfswinkel, Gerhard
Arntz, Mark J. https://orcid.org/0000-0002-2402-7617
Janssen, Marcel J. R. https://orcid.org/0000-0002-2567-7734
Roosen, Joey https://orcid.org/0000-0002-7965-6664
Nijsen, J. Frank W. https://orcid.org/0000-0001-7625-2253
-
Funding
Funding for this research was provided by:
Terumo (Terumo)
- License Information
-
More Information
Article History
Received: 24 May 2024
Accepted: 10 October 2024
First Online: 16 October 2024
Declarations
:
: was obtained via the METC Oost-nederland, ref. NL78931.091.21. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Clinicaltrials.gov identifier: NCT05183776, registered on January 7th, 2022.
: All data presented in this article was obtained from individuals that provided informed written consent.
: JFWN is co-founder and scientific advisor of Quirem Medical which has been acquired by Terumo Europe NV in July 2020. The activities of JFWN within Quirem Medical are approved and supported by the Board of Directors of the Radboudumc. JFWN Nijsen is entitled to certain milestone payments from Terumo which are related to Quirem’s financial, operational and regulatory performance in the future. GW is an employee of Quirem Medical B.V. The other authors declare that they have no financial or non-financial conflict of interest.
